W311:XETRA:XETRA-HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF - Accumulating (EUR)

ETF | Others |

Last Closing

USD 5.674

Change

+0.02 (+0.41)%

Market Cap

N/A

Volume

141.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-09 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

-0.11 (-0.24%)

USD 100.65B
EUNL:XETRA iShares Core MSCI World UCITS ..

-0.05 (-0.05%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.01 (+0.04%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

-0.06 (-0.47%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

-0.03 (-0.60%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

+0.02 (+0.09%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

-0.04 (-0.30%)

USD 23.49B
PPFB:XETRA iShares Physical Gold ETC EUR

+0.02 (+0.03%)

USD 20.66B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

-0.04 (-0.43%)

USD 12.74B
EUN5:XETRA iShares Core Corporate Bond UC..

-0.03 (-0.02%)

USD 12.26B

ETFs Containing W311:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -10.88% 16% F 17% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -10.88% 19% F 20% F
Trailing 12 Months  
Capital Gain -11.58% 10% F 16% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -11.58% 12% F 17% F
Trailing 5 Years  
Capital Gain -29.82% 3% F 9% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return -29.82% 4% F 8% B-
Average Annual (5 Year Horizon)  
Capital Gain -6.24% 6% D- 10% F
Dividend Return -6.24% 6% D- 9% A-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 14.05% 39% F 51% F
Risk Adjusted Return -44.45% 11% F 11% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.